HCPCS Code A4253: Blood glucose test strips billing guide

Key Takeaways

HCPCS Code A4253 describes blood glucose test or reagent strips for a home blood glucose monitor, billed per 50 strips per unit of service.

Medicare Part B covers A4253 under LCD L33822; quantity limits differ based on whether the patient uses insulin, regardless of Type 1 or Type 2 classification.

In a past post-payment review, Noridian found an 84% improper payment rate for A4253, making accurate documentation and ICD-10 diagnosis code pairing a compliance priority.

Practice management software like Pabau helps DMEPOS suppliers and practices track billing documentation, reduce claim errors, and stay audit-ready with built-in claims management tools.

HCPCS Code A4253: Definition and clinical description

HCPCS Code A4253 covers blood glucose test or reagent strips for a home blood glucose monitor, billed per 50 strips. DMEPOS suppliers and healthcare providers use this code when furnishing single-use strips that patients with diabetes use to measure capillary blood glucose at home.

It has been active since January 1, 1986, with no maintenance action code, and remains a high-volume supply code under the Medicare DMEPOS program.

The code sits within the HCPCS Level II A-code range, which covers medical and surgical supplies. According to the Centers for Medicare and Medicaid Services (CMS) HCPCS overview, CMS maintains Level II codes annually and updates them to cover items not captured in CPT.

A4253 is one of several interrelated supply codes that DMEPOS suppliers bill alongside lancets, platforms, and monitoring systems.

A critical distinction for correct billing: HCPCS Code A4253 applies to traditional home blood glucose monitor (BGM) strips only. It does not apply to continuous glucose monitor (CGM) supplies, such as external CGM receivers, which use separate HCPCS codes. Post-payment reviews frequently flag confusing BGM strips with CGM supplies as one of the most common errors.

Related A-codes used alongside A4253

Billing A4253 accurately often requires understanding adjacent codes. The table below summarizes the most frequently paired HCPCS supply codes.

Using A4772 instead of A4253 for a home-use patient, or billing A4252 for standard glucose monitoring, will trigger a claim edit. Verify the clinical context before selecting any adjacent code. Suppliers using claims management software can flag these code substitution errors before submission.

DMEPOS suppliers managing a broader supply catalog may also bill related codes such as enteral feeding supply kits (B4035), pressure-reducing mattress overlays (E0181), and innerspring mattresses (E0271), each with its own documentation and modifier requirements.

Medicare quantity limits and units of service for HCPCS Code A4253

Under CMS Policy Article A52464, one unit of service for HCPCS Code A4253 equals 50 strips. Billing 100 strips requires billing 2 units. Billing 150 strips requires billing 3 units. This unit definition is fixed and applies across all Medicare administrative contractors (MACs).

Quantity limits by insulin treatment status

Quantity limits under Local Coverage Determination (LCD) L33822 apply per 3 months and depend on the beneficiary’s treatment regimen, not their diabetes type. The key variable is whether the patient is treated with insulin. Insulin use is typically supported in the record with ICD-10-CM code Z79.4 (long-term use of insulin) alongside the diabetes diagnosis.

Quantities above the default allowance per 3 months require a physician’s order with documented clinical justification. Suppliers billing for higher quantities must also confirm the beneficiary had an in-person or telehealth visit with the treating practitioner within the prior 6 months, and that visit needs reverifying every 6 months to maintain coverage.

In a past post-payment review, Noridian found that billing beyond covered quantities without adequate documentation was the primary driver behind an 84% improper payment rate for HCPCS Code A4253 claims. Treat quantity limits as a hard ceiling unless a written order justifies exceeding them.

LCD L33822 coverage requirements and diagnosis codes

Medicare covers HCPCS Code A4253 under LCD L33822 (Glucose Monitors). Coverage applies when the beneficiary has a documented diabetes diagnosis and uses a home blood glucose monitor that requires test strips. The treating physician must order the strips, and the order must reflect the patient’s testing regimen.

Every A4253 claim requires diagnosis code pairing. The table below lists the ICD-10-CM codes most commonly paired with this supply code. Using a non-covered diagnosis code, or omitting a diagnosis code entirely, will result in an automatic denial.

Select the most specific available code. E11.65 (Type 2 diabetes mellitus with hyperglycemia) is a valid paired code; E11 alone is not. The claim must carry the 4th and 5th character specificity that reflects the patient’s documented clinical status.

For coding reference, HCPCS lookup tools provide A4253 crosswalk data, including paired ICD-10-CM codes and LCD policy links. Practices managing high patient volumes benefit from digital intake forms that capture diabetes type and treatment regimen at the point of care, making diagnosis code selection more accurate downstream.

DMEPOS supplier enrollment requirement

To bill HCPCS Code A4253 to Medicare, the supplier must enroll as a DMEPOS supplier with a valid Medicare billing number. Physician practices that dispense strips directly must also hold DMEPOS enrollment or arrange supply through a licensed DMEPOS supplier.

Billing without enrollment results in claim rejection at the MAC level rather than a denial — the claim never reaches processing. DMEPOS enrollment requirements apply consistently across supply categories: suppliers billing HCPCS code L1810 (knee orthosis) face the same enrollment threshold as those billing A4253.

Practices that support patients with metabolic health conditions and manage DMEPOS supply workflows should therefore confirm their billing infrastructure before billing A4253. The National Mail-Order Competitive Bidding Program governs reimbursement for A4253 nationwide, rather than only in designated competitive bidding areas. Suppliers billing mail-order claims must append the KL modifier.

In addition, since 2013, the American Taxpayer Relief Act has equalized mail-order and non-mail-order payment rates for diabetic testing supplies. Rates under the fee schedule still change annually, so verify the current 2026 DME fee schedule for A4253 with your MAC before setting patient expectations around copay amounts.

Keep your DMEPOS billing accurate and audit-ready

Pabau's claims management tools help DMEPOS suppliers and healthcare practices reduce coding errors, track documentation, and stay compliant with Medicare LCD requirements. See how it works with a quick demo.

Book a demo

Payer-specific policies and prior authorization for A4253

Coverage rules for HCPCS Code A4253 vary across payers. Medicare is the most structured, but commercial insurers and state Medicaid programs apply their own quantity limits, prior authorization requirements, and product-specific rules. Never assume Medicare’s LCD L33822 policy applies to a commercial claim without verifying the specific plan’s medical policy.

Blue Cross Blue Shield of Florida

BCBS FL limits HCPCS Code A4253 to 6 to 8 units per 3-month period under medical coverage guideline MCG 09-E0000-14 (reviewed August 28, 2025). In other words, that equates to 300 to 400 strips per quarter.

Claims exceeding this threshold without prior authorization face denial. Suppliers billing BCBS FL should therefore verify the current policy version before submitting, as BCBS FL reviews and updates coverage guidelines periodically.

New York Medicaid (emedNY)

Effective October 1, 2023, New York Medicaid updated its A4253 policy to let suppliers bill Accu-Chek Guide Test Strips compatible with the MiniMed (Medtronic) insulin delivery system under HCPCS Code A4253. New York Medicaid published this change in the emedNY provider manual dated October 3, 2023.

As a result, strips previously not covered under this code for that device became billable. Suppliers in New York serving Medicaid patients using Medtronic systems should confirm current formulary status before billing.

Texas Medicaid (TMHP CSHCN)

Under the Texas Medicaid Children with Special Health Care Needs (CSHCN) Services Program, the CSHCN Services Program Provider Manual (April 2025 revision) limits the A4253 strip allowance to four boxes of test strips (and two boxes of A4259 lancets) per calendar year for patients with an approved CGM system. This reflects the expectation that CGM supplies take on primary monitoring responsibility.

As a result, billing beyond this allowance for a patient already receiving CGM supplies may trigger a post-payment review inquiry. Practices serving pediatric or complex-needs populations in Texas should therefore verify applicable limits through the current TMHP CSHCN provider manual. For a broader understanding of how billing codes interact with practice management workflows, the practice management software guide covers relevant operational considerations.

Documentation requirements and compliance for HCPCS Code A4253

In a past post-payment review, Noridian found an 84% improper payment rate for HCPCS Code A4253 claims, based on dollars reviewed. That figure reflected systemic documentation shortfalls that affected DMEPOS billing broadly, not isolated errors.

However, more recent Targeted Probe and Educate audits show a considerably lower current risk picture: Jurisdiction A reported a 7% improper payment rate for January through March 2025, and Jurisdiction D reported 14% for October through December 2025. Even with improved rates, the most common deficiencies still involve missing or insufficient physician orders, absent clinical necessity documentation, and strip quantities that exceed the ordered testing frequency.

Minimum documentation elements

Every A4253 claim submitted to Medicare must include the following documentation elements in the patient’s file at the time of billing.

• Physician’s order: Must specify the type of monitor, the strip brand or code, and the testing frequency (e.g., “test blood glucose 3 times daily”).
• Diagnosis documentation: The medical record must support the paired ICD-10-CM code. A claim coded to E11.65 requires documentation showing hyperglycemia, not just a generic diabetes diagnosis entry. An A1C calculator can help confirm the documented glycemic control aligns with the coded severity.
• Treating physician identity: The claim must identify the ordering physician. Anonymous or illegible orders are not sufficient.
• Proof of delivery: For DMEPOS supplies, suppliers must retain a signed delivery receipt or shipping confirmation, since Medicare requires proof of delivery for A4253 claims.
• Refill documentation: Before dispensing a refill, the supplier must document a beneficiary contact confirming the supplies are still needed, per 42 CFR 410.38 and CMS guidance in MM13480 — suppliers cannot ship refills automatically on a calendar schedule. Dates of service must be spanned to match the expected supply duration. Every claim line must also carry the KX modifier for insulin-treated beneficiaries or the KS modifier for non-insulin-treated beneficiaries, matching the insulin/non-insulin quantity limits described above. Modifier rules follow similar logic for other supply categories, such as HCPCS code E0100 (cane) and HCPCS code L1200 (TLSO), which each carry their own category-specific modifier requirements.

Practices managing diabetes supply workflows should maintain a documentation checklist that mirrors these requirements. Coding reference tools can verify code properties before submission. For broader billing compliance across a practice or DMEPOS operation, the HIPAA compliance framework for medical offices provides a practical starting reference.

ABN requirements when coverage is denied

When a DMEPOS supplier has reason to believe Medicare will deny an A4253 claim because the quantity exceeds covered limits or the patient’s diagnosis does not support medical necessity, the supplier must issue an Advance Beneficiary Notice of Noncoverage (ABN) before furnishing the supplies.

Without a valid ABN, the supplier cannot bill the patient for denied items. The ABN must be specific: it must identify the item (blood glucose test strips, HCPCS Code A4253), the reason Medicare may not pay, and the estimated cost to the patient.

By using structured medical forms workflows, suppliers can integrate ABN issuance into their standard pre-supply process, reducing the risk of furnishing supplies without a signed notice. A HIPAA compliance checklist for primary care can help align ABN and documentation workflows with broader privacy requirements.

Practices that also handle other procedure codes alongside supply billing benefit most from a unified documentation approach that captures all required elements in a single workflow step.

Conclusion

HCPCS Code A4253 carries a straightforward descriptor but a complex billing environment. Quantity limits vary by treatment regimen and payer, coders must specify diagnosis codes at the 4th and 5th character level, and documentation shortfalls were the primary driver behind an 84% improper payment rate that Noridian flagged in a past post-payment review — though more recent Targeted Probe and Educate audits report considerably lower rates, in the 7% to 14% range.

Getting A4253 billing right still requires verified physician orders, accurate ICD-10 pairing, proof of delivery, and payer-specific policy awareness before each claim cycle.

Pabau’s claims management software helps practices and DMEPOS suppliers track the documentation requirements that prevent denials. To see how Pabau handles DMEPOS billing workflows, book a demo.

Continue your research

Billing other procedure codes alongside DMEPOS supplies? IVF CPT codes reference guide shows how structured billing workflows apply across specialty supply and procedure coding.

Frequently Asked Questions